Product Information
DEXTROAMP-AMPHET ER 30 MG CAP is a generic product labeled by Elite Laboratories, Inc., priced at $0.5227 per EA under NDC 64850051501. Its NADAC has been published 160 times since Jun 7, 2023.
DEXTROAMP-AMPHET ER 30 MG CAP
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Elite Laboratories, Inc.NDC
64850051501
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA212037On Market Since
12/16/2019
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has been published 160 times since Jun 7, 2023, and over the history we have for it it has declined 18.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5227 per EA |
|---|---|
| All-time high | $0.7671 (Nov 13, 2024) |
| All-time low | $0.3360 (May 22, 2024) |
| 52-week high | $0.5944 |
| 52-week low | $0.4621 |
| Median price | $0.5843 |
| Average price | $0.5726 |
| Largest weekly change | +61.4% (Jun 19, 2024) |
| Weeks tracked | 160 |
| Tracking since | Jun 7, 2023 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 30 MG CAP, manufactured by Elite Laboratories, Inc., is $0.5227 per EA (NDC 64850051501), effective Jun 24, 2026.
How has the price of DEXTROAMP-AMPHET ER 30 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has declined 18.8%. It has been tracked across 160 weekly CMS publications since Jun 7, 2023.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 30 MG CAP?
Since Jun 7, 2023, the NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has ranged from a low of $0.3360 (May 22, 2024) to a high of $0.7671 (Nov 13, 2024), with a median of $0.5843 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 30 MG CAP?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DEXTROAMP-AMPHETAMIN 30 MG TAB, is $0.3048 per EA — about 42% below DEXTROAMP-AMPHET ER 30 MG CAP.
Who manufactures DEXTROAMP-AMPHET ER 30 MG CAP?
DEXTROAMP-AMPHET ER 30 MG CAP (NDC 64850051501) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification